Celeatherapeutics
VerifiedWork at Celeatherapeutics.
Celea Therapeutics, Inc. is a Boston-based clinical-stage biopharmaceutical company focused on developing treatments for serious respiratory diseases. Its lead investigational product, deupirfenidone (LYT-100), is a next-generation oral antifibrotic in Phase 3 development for idiopathic...
Healthcare
Open roles
1
Founded
2024
Type
Private
Team size
11–50
Headquarters
Boston
Website
puretechhealth.com
View on LinkedIn →
Open roles at Celeatherapeutics
1 open rolesSubscribe to Career Resources.
Get the latest career advice, industry insights, and job opportunities delivered straight to your inbox.
